Biocompatibility of polyetheretherketone for the treatment of orbital bone defects

10Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

AIM: To investigate the biocompatibility and therapeutic effects of polyetheretherketone (PEEK) on recovery of a rabbit orbital defect. METHODS: Totally 16 New Zealand rabbits were used to establish an orbital bone defect model and then randomly divided into two groups. PEEK was implanted in the experimental group. The control group was blank, and no substance was implanted. The model rabbits were sacrificed at 4 and 8wk, and examined by general observations, histology, electron microscopy, Western blotting, and real-time polymerase chain reaction. RESULTS: No infection or rejection occurred after PEEK implantation, and biocompatibility was good. The relative expression of vascular endothelial growth factor (VEGF) protein in the experimental group was significantly higher than that in the control group postoperatively (P<0.05). Bone defect repair in the experimental group was significantly better than that in the control group in the same period and some osteogenesis was observed. CONCLUSION: PEEK has good biocompatibility and efficacy for the treatment of orbital bone defects in a rabbit model.

Cite

CITATION STYLE

APA

Gu, R. D., Xiao, F., Wang, L., Sun, K. J., & Chen, L. L. (2020). Biocompatibility of polyetheretherketone for the treatment of orbital bone defects. International Journal of Ophthalmology, 13(5), 725–730. https://doi.org/10.18240/ijo.2020.05.05

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free